Mice lacking DYRK2 exhibit congenital malformations with lung hypoplasia and altered Foxf1 expression gradient

Satomi Yogosawa1, Makiko Ohkido2, Takuro Horii3

  • 1Department of Biochemistry, The Jikei University School of Medicine, Tokyo, Japan.

Communications Biology
|October 21, 2021
PubMed

Insights

Dyrk2 deficiency causes congenital malformations and respiratory failure in newborn mice by disrupting lung development and Foxf1 expression. Restoring Shh signaling partially rescues these defects.

Area of Science:

  • Developmental Biology
  • Genetics
  • Pediatric Pathology

Background:

  • Congenital malformations pose significant risks in pediatrics.
  • The molecular underpinnings of organogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of Dyrk2 in organogenesis and its potential link to congenital malformations.
  • To elucidate the molecular mechanisms underlying Dyrk2-deficiency-induced developmental defects, focusing on lung development.

Main Methods:

  • Generation and analysis of Dyrk2-deficient mice.
  • Transcriptome analysis to identify molecular pathologies.
  • Detailed histological and developmental analyses of primordial lungs.
  • Ex vivo lung culture to test rescue strategies.

Main Results:

  • Dyrk2-deficient mice exhibit multiple congenital malformations and post-natal lethality due to respiratory failure.
  • Reduced Foxf1 expression and disrupted signaling pathways were observed in Dyrk2-deficient lungs.
  • Impaired airway branching and alveolar development were evident in mutant lungs.
  • Restoration of Shh signaling in ex vivo cultures partially rescued Foxf1 expression and target genes.

Conclusions:

  • Dyrk2 is crucial for mammalian embryogenesis and proper organ development.
  • Disruption of Dyrk2 leads to congenital malformations, particularly affecting lung morphogenesis via Foxf1 regulation.
  • Shh signaling pathway modulation presents a potential therapeutic avenue for Dyrk2-related developmental disorders.